These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29102959)

  • 1. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Aug; 394(10196):396-406. PubMed ID: 31248662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
    Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
    Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
    Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
    Mathur VS; Wesson DE; Tangri N; Li E; Bushinsky DA
    BMC Nephrol; 2022 Feb; 23(1):82. PubMed ID: 35216581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
    Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Mohebbi N; Ritter A; Wiegand A; Graf N; Dahdal S; Sidler D; Arampatzis S; Hadaya K; Mueller TF; Wagner CA; Wüthrich RP
    Lancet; 2023 Feb; 401(10376):557-567. PubMed ID: 36708734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.
    BiCARB study group
    BMC Med; 2020 Apr; 18(1):91. PubMed ID: 32268897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral sodium bicarbonate in patients with CKD.
    Abramowitz MK; Melamed ML; Bauer C; Raff AC; Hostetter TH
    Clin J Am Soc Nephrol; 2013 May; 8(5):714-20. PubMed ID: 23393105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.